Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Sep 13;293(6548):678–680. doi: 10.1136/bmj.293.6548.678

Use and misuse of a digoxin assay service.

I Gibb, J C Cowan, A J Parnham, T H Thomas
PMCID: PMC1341522  PMID: 3756451

Abstract

In a study of the use of a digoxin assay service and its influence on clinical management 285 assay requests were audited over 12 weeks. For 67 (24%) there was no clear clinical indication for the request and for 140 the period between the last dose of digoxin being given and the blood sample being taken was either unknown or inappropriate. Treatment in 64 patients (22%) was changed after the assay result was received [corrected]. 24 of these changes bore no relation to the original clinical indication for requesting the assay, suggesting that such changes were based on the assay result alone. Of samples collected within six hours after the last dose, 15 of 69 (22%) led to a reduction in treatment compared with 10 of 116 (9%) taken after six hours (p less than 0.025), thereby highlighting the danger that incorrectly timed samples may lead to inappropriate clinical decisions.

Full text

PDF
678

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronson J. K. Indications for the measurement of plasma digoxin concentrations. Drugs. 1983 Sep;26(3):230–242. doi: 10.2165/00003495-198326030-00004. [DOI] [PubMed] [Google Scholar]
  2. Brodie M. J., McIntosh M. E., Hallworth M. Therapeutic drug monitoring--the need for audit? Scott Med J. 1985 Apr;30(2):75–82. doi: 10.1177/003693308503000202. [DOI] [PubMed] [Google Scholar]
  3. Clague H. W., Twum-Barima Y., Carruthers S. G. An audit of requests for therapeutic drug monitoring of digoxin: problems and pitfalls. Ther Drug Monit. 1983;5(3):249–254. doi: 10.1097/00007691-198309000-00003. [DOI] [PubMed] [Google Scholar]
  4. Goldman S., Probst P., Selzer A., Cohn K. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Am J Cardiol. 1975 May;35(5):651–655. doi: 10.1016/0002-9149(75)90051-x. [DOI] [PubMed] [Google Scholar]
  5. Nicholson P. W., Dobbs S. M., Rodgers E. M. Ideal sampling time for drug assays. Br J Clin Pharmacol. 1980 May;9(5):467–470. doi: 10.1111/j.1365-2125.1980.tb05841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Slaughter R. L., Schneider P. J., Visconti J. A. Appropriateness of the use of serum digoxin and digitoxin assays. Am J Hosp Pharm. 1978 Nov;35(11):1376–1379. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES